The scenario of genetic alterations contributing to melanoma gene signature was completed by somatic CNVs, such as gene amplifications in CCND1, CDK4, KIT, MITF, and TERT as well as gene deletions in CDKN2A and PTEN. Here, CDKN2A is linked to melanoma.